Bridgebio Oncology Therapeutics, Inc. (BBOT)
7.31
-0.47
(-6.04%)
USD |
NASDAQ |
Jun 09, 16:00
7.31
0.00 (0.00%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics EPS Diluted (Quarterly) : -526.11 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Erasca, Inc. | -0.6028 |
| Bicara Therapeutics, Inc. | -0.9258 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.11M |
| Total Expenses (Quarterly) | 42.11M |
| Enterprise Value | 373.46M |
| Earnings Yield | -7.22K% |
| Normalized Earnings Yield | -7217.37 |